Quoted Micro 11 November 2024

AQUIS STOCK EXCHANGE Cross border e-commerce technology company Samarkand Group (SMK) reported a dip in revenues of 22% to £6.3m, with owned brands increasing their contribution by 14% to £4.1m. The loss has been reduced even before the £1.08m gain on the disposal of a brand. Net debt is £2m. The switch to focusing on […]

Quoted Micro 19 August 2024

AQUIS STOCK EXCHANGE ProBiotix Health (PBX) has secured a commercial agreement for InstaMelt with DanCare Health. InstaMelt is a food supplement dosage format that offers innovative features for health brands. DanCare will launch the supplement in China in the fourth quarter under its own brand. Samarkand (SMK) reported a dip in full year revenues from […]

Quoted Micro 28 August 2023

AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) has received a general meeting requisition from one of its shareholders. The directors are reviewing the request. Technology marketing start-up Inteliqo (IQO) generated income of more than $400,000 and pre-tax profit of $250,000 from the distribution rights of the Langaroo app, which has still to be launched on […]

Summer and the Markets – Alan Green talks to Doc Holliday

Alan Green catches up again with investor and market trader Doc Holliday. We discuss the poor sentiment and the lack of momentum and liquidity in the markets, and Doc gives his view on what investors should be doing at this time – in particular don’t sit and be a victim of the market! We then […]

Managing the Transition to Clean Energy – Q&A with James Parsons

Managing the Transition to Clean Energy – Q&A with James Parsons Q     So much seems to be happening globally around the energy transition at the moment, from big companies such as the oil majors to the micro cap space. How do you see the transition at the moment? It has been an exciting […]

Andrew Hore – Quoted Micro 3 August 2020

AQUIS STOCK EXCHANGE Newbury Racecourse (NYR) says that it is confident that it has the resources to trade through the current economic difficulties. Significant losses are expected this year and into next year. There was £1.27m in the bank at the end of 2019. Net assets were £50.9m. Newbury increased revenues by 3% to £19.8m […]

Andrew Hore Quoted Micro 9 December 2019

NEX EXCHANGE GP clinical software supplier DXS International (DXSP) broadly maintained its interim revenues at £1.66m. Admin costs were lower so DXS returned to profit. There was also a higher tax credit. It made a pre-tax profit of £90,000 in the six months to October 2019, while the post-tax figure was £202,000. The final accreditation […]